In vitro effects of lead on gene expression in neural stem cells and associations between up-regulated genes and cognitive scores in children

Environmental Health Perspectives

Volumn 125, Issue 4, 2017, Pages 721-729

  Wagner, Peter J ^a   Park, Hae Ryung ^a   Wang, Zhaoxi ^a   Kirchner, Rory ^a   Wei, Yongyue ^a   Su, Li ^a   Stanfield, Kirstie ^b   Guilarte, Tomas R ^b   Wright, Robert O ^c   Christiani, David C ^a   Lu, Quan ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Columbia University Mailman School of Public Health ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; EPIDERMAL GROWTH FACTOR; HEME OXYGENASE 1; LEAD; NERVE GROWTH FACTOR; OSTEOPONTIN; PROTHROMBIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR NRF2; DANGEROUS GOODS; SPP1 PROTEIN, HUMAN;

ARTICLE; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; COGNITION ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE LIBRARY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MATERNAL EXPOSURE; MTT ASSAY; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPP1 GENE; TRANSCRIPTOMICS; UPREGULATION; WESTERN BLOTTING; CHILD; DANGEROUS GOODS; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SIGNAL TRANSDUCTION; TOXICITY;

CHILD; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HAZARDOUS SUBSTANCES; HUMANS; LEAD; NEURAL STEM CELLS; NEUROPSYCHOLOGICAL TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 85016773833     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/EHP265     Document Type: Article

References (68)

1. Albertsson AM, Zhang X, Leavenworth J, Bi D, Nair S, Qiao L, et al. 2014. The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. J Neuroinflammation 11:197, doi: 10.1186/s12974-014-0197-0.
2. Alkondon M, Costa AC, Radhakrishnan V, Aronstam RS, Albuquerque EX. 1990. Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett 261:124–130.
3. Bass V, Gordon CJ, Jarema KA, MacPhail RC, Cascio WE, Phillips PM, et al. 2013. Ozone induces glucose intolerance and systemic metabolic effects in young and aged Brown Norway rats. Toxicol Appl Pharmacol 273:551–560.
4. Bayley N. 2005. Bayley Scales of Infant and Toddler Development. 3rd ed. San Antonio, TX:Pearson.
5. Bellinger DC. 2013. Prenatal exposures to environmental chemicals and children’s neurodevelopment: an update. Saf Health Work 4:1–11.
6. Bellinger DC. 2016. Lead contamination in Flint—an abject failure to protect public health. N Engl J Med 374:1101–1103.
7. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. 1987. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 316:1037–1043.
8. Breier JM, Radio NM, Mundy WR, Shafer TJ. 2008. Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalized human neural progenitor cells. Toxicol Sci 105:119–133.
9. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med 348:1517–1526.
10. Chan JL, Reeves TM, Phillips LL. 2014. Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury. Exp Neurol 261:757–771.
11. Chen YJ, Wei YY, Chen HT, Fong YC, Hsu CJ, Tsai CH, et al. 2009. Osteopontin increases migration and MMP-9 up-regulation via αvβ3 integrin, FAK, ERK, and NF-κB-dependent pathway in human chondrosarcoma cells. J Cell Physiol 221:98–108.
12. Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR. 2005. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38:325–343.
13. Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, et al. 2012. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res 40:7416–7429.
14. Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT. 2002. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J Biol Chem 277:30730–30737.
15. Ettinger AS, Lamadrid-Figueroa H, Téllez-Rojo MM, Mercado-García A, Peterson KE, Schwartz J, et al. 2009. Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect 117:26–31, doi: 10.1289/ehp.11868.
16. Fong YC, Liu SC, Huang CY, Li TM, Hsu SF, Kao ST, et al. 2009. Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/ FAK/Akt and NF-κB-dependent pathway. Lung Cancer 64:263–270.
17. Fulton M, Raab G, Thomson G, Laxen D, Hunter R, Hepburn W. 1987. Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet 1:1221–1226.
18. Gilbert ME, Kelly ME, Samsam TE, Goodman JH. 2005. Chronic developmental lead exposure reduces neurogenesis in adult rat hippocampus but does not impair spatial learning. Toxicol Sci 86:365–374.
19. González-Cossío T, Peterson KE, Sanín LH, Fishbein E, Palazuelos E, Aro A, et al. 1997. Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics 100:856–862.
20. Guilarte TR, Burton NC, Verina T, Prabhu VV, Becker KG, Syversen T, et al. 2008. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J Neurochem 105:1948–1959.
21. 3H]MK-801 binding to the NMDA receptor-gated ionophore: in vitro and in vivo studies. Neurosci Lett 148:27–30.
22. Hernandez-Avila M, Peterson KE, Gonzalez-Cossio T, Sanin LH, Aro A, Schnaas L, et al. 2002. Effect of maternal bone lead on length and head circumference of newborns and 1-month-old infants. Arch Environ Health 57:482–488.
23. Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, et al. 2006. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 114:1730–1735, doi: 10.1289/ehp.9067.
24. Huang F, Schneider JS. 2004. Effects of lead exposure on proliferation and differentiation of neural stem cells derived from different regions of embryonic rat brain. Neurotoxicology 25:1001–1012.
25. International HapMap Consortium. 2003. The International HapMap Project. Nature 426:789–796.
26. Jones RL, Homa DM, Meyer PA, Brody DJ, Caldwell KL, Pirkle JL, et al. 2009. Trends in blood lead levels and blood lead testing among US children aged 1 to 5 years, 1988–2004. Pediatrics 123:e376–e385.
27. Kalluri HS, Dempsey RJ. 2012. Osteopontin increases the proliferation of neural progenitor cells. Int J Dev Neurosci 30:359–362.
28. Kensler TW, Wakabayashi N, Biswal S. 2007. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89–116.
29. Kim NR, Lim BS, Park HC, Son KM, Yang HC. 2011. Effects of N-acetylcysteine on TEGDMA- and HEMA-induced suppression of osteogenic differentiation of human osteosarcoma MG63 cells. J Biomed Mater Res B Appl Biomater 98:300–307.
30. Kook SH, Kim KA, Ji H, Lee D, Lee JC. 2015. Irradiation inhibits the maturation and mineralization of osteoblasts via the activation of Nrf2/HO-1 pathway. Mol Cell Biochem 410:255–266.
31. Korashy HM, El-Kadi AO. 2006. Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper. Drug Metab Dispos 34:152–165.
32. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. 2003. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278:12029–12038.
33. Levin ED. 2016. Crumbling infrastructure and learning impairment: a call for responsibility [Editorial]. Environ Health Perspect 124:A79, doi: 10.1289/EHP69.
34. Li J, Ji L. 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95:221–227.
35. Li J, Lee JM, Johnson JA. 2002. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J Biol Chem 277:388–394.
36. Lu DY, Yeh WL, Huang SM, Tang CH, Lin HY, Chou SJ. 2012. Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro Oncol 14:1367–1378.
37. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, et al. 2010. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38:5718–5734.
38. Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17:10–12.
39. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, et al. 2005. Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab 25:217–225.
40. Neal AP, Stansfield KH, Worley PF, Thompson RE, Guilarte TR. 2010. Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling. Toxicol Sci 116:249–263.
41. Neal AP, Worley PF, Guilarte TR. 2011. Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition. Neurotoxicology 32:281–289.
42. Needleman HL, Gunnoe C, Leviton A, Reed R, Peresie H, Maher C, et al. 1979. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 300:689–695.
43. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. 1996. Bone lead levels and delinquent behavior. JAMA 275:363–369.
44. Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, et al. 2004. Prenatal lead exposure, δ-aminolevulinic acid, and schizophrenia. Environ Health Perspect 112:548–552, doi: 10.1289/ehp.6777.
45. Opler MG, Buka SL, Groeger J, McKeague I, Wei C, Factor-Litvak P, et al. 2008. Prenatal exposure to lead, δ-aminolevulinic acid, and schizophrenia: further evidence. Environ Health Perspect 116:1586–1590, doi: 10.1289/ehp.10464.
46. Peterson SM, Zhang J, Weber G, Freeman JL. 2011. Global gene expression analysis reveals dynamic and developmental stage-dependent enrichment of lead-induced neurological gene alterations. Environ Health Perspect 119:615–621, doi: 10.1289/ehp.1002590.
47. Pirkle JL, Brody DJ, Gunter EW, Kramer RA, Paschal DC, Flegal KM, et al. 1994. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES). JAMA 272:284–291.
48. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575.
49. Rabenstein M, Hucklenbroich J, Willuweit A, Ladwig A, Fink GR, Schroeter M, et al. 2015. Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4. Stem Cell Res Ther 6:99, doi: 10.1186/s13287-015-0098-x.
50. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11:R25, doi: 10.1186/gb-2010-11-3-r25.
51. Sánchez-Martín FJ, Fan Y, Lindquist DM, Xia Y, Puga A. 2013. Lead induces similar gene expression changes in brains of gestationally exposed adult mice and in neurons differentiated from mouse embryonic stem cells. PloS One 8:e80558, doi: 10.1371/journal.pone.0080558.
52. Schneider JS, Anderson DW, Talsania K, Mettil W, Vadigepalli R. 2012. Effects of developmental lead exposure on the hippocampal transcriptome: influences of sex, developmental period, and lead exposure level. Toxicol Sci 129:108–125.
53. Schneider JS, Anderson DW, Wade TV, Smith MG, Leibrandt P, Zuck L, et al. 2005. Inhibition of progenitor cell proliferation in the dentate gyrus of rats following post-weaning lead exposure. Neurotoxicology 26:141–145.
54. Senut MC, Sen A, Cingolani P, Shaik A, Land SJ, Ruden DM. 2014. Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation. Toxicol Sci 139:142–161.
55. H17 inflammation in human and experimental emphysema. Sci Transl Med 4:117ra9, doi: 10.1126/scitranslmed.3003041.
56. Simmons SO, Fan CY, Yeoman K, Wakefield J, Ramabhadran R. 2011. Nrf2 oxidative stress induced by heavy metals is cell type dependent. Curr Chem Genomics 5:1–12.
57. 2+: implications for an environmental basis of neurodevelopmental disorders. Toxicol Sci 127:277–295.
58. Thai P, Statt S, Chen CH, Liang E, Campbell C, Wu R. 2013. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol 49:204–211.
59. Topkoru BC, Altay O, Duris K, Krafft PR, Yan J, Zhang JH. 2013. Nasal administration of recombi-nant osteopontin attenuates early brain injury after subarachnoid hemorrhage. Stroke 44:3189–3194.
60. Toscano CD, Guilarte TR. 2005. Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev 49:529–554.
61. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111.
62. Vangipuram SD, Grever WE, Parker GC, Lyman WD. 2008. Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. Alcohol Clin Exp Res 32:339–347.
63. Verina T, Rohde CA, Guilarte TR. 2007. Environmental lead exposure during early life alters granule cell neurogenesis and morphology in the hippocampus of young adult rats. Neuroscience 145:1037–1047.
64. Wang X, Tomso DJ, Chorley BN, Cho HY, Cheung VG, Kleeberger SR, et al. 2007. Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet 16:1188–1200.
65. Wasserman GA, Liu X, Lolacono NJ, Factor-Litvak P, Kline JK, Popovac D, et al. 1997. Lead exposure and intelligence in 7-year-old children: the Yugoslavia Prospective Study. Environ Health Perspect 105:956–962.
66. Yang L, Kemadjou JR, Zinsmeister C, Bauer M, Legradi J, Müller F, et al. 2007. Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biol 8:R227, doi: 10.1186/gb-2007-8-10-r227.
67. Zeller I, Knoflach M, Seubert A, Kreutmayer SB, Stelzmüller ME, Wallnoefer E, et al. 2010. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells. Arterioscler Thromb Vasc Biol 30:1733–1740.
68. Zheng L, Wu K, Li Y, Qi Z, Han D, Zhang B, et al. 2008. Blood lead and cadmium levels and relevant factors among children from an e-waste recycling town in China. Environ Res 108:15–20.